ESSA Pharma Inc.

Canada


Create a watch for ESSA Pharma Inc.
Total IP 43
Total IP Rank # 33,261
IP Activity Score 2.5/5.0    34
IP Activity Rank # 22,202
Stock Symbol
ISIN CA29668H7085
Market Cap. 93.11M
Industry Pharmaceuticals
Sector Life Sciences
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

15 3
7 3
14 1
0
 
Last Patent 2024 - Combination therapies for metast...
First Patent 2019 - Androgen receptor modulators and...
Last Trademark 2022 - ANITAC
First Trademark 2017 - ESSA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2023 Invention Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof. The present in...
Invention An n-terminal domain androgen receptor inhibitor and uses thereof. The present disclosure general...
Invention Androgen receptor modulators and methods for their use. The present invention relates to compoun...
Invention Androgen receptor modulators and methods for their use. The present invention relates to compound...
2022 Invention Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof. The present inv...
Invention Androgen receptor modulators and methods for use as bifunctional degraders. The present invention...
Invention Combination therapies for metastatic castration-resistant prostate cancer. Provided herein are t...
Invention Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and u...
Invention Combination therapies for metastatic castration-resistant prostate cancer. Provided herein are th...
G/S Chemical compounds for pharmaceutical purposes and pharmaceutical preparations for the treatment ...
G/S Chemical compounds and pharmaceutical preparations for the treatment of cancer, autoimmune disea...
Invention Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereof. The...
Invention Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereof. The ...
G/S Pharmaceutical compounds and preparations for the treatment of cancer, autoimmune diseases, infla...
2020 Invention Androgen receptor modulators and methods for use as proteolysis targeting chimera ligands. The p...
Invention Androgen receptor modulators and methods for use as proteolysis targeting chimera ligands. The pr...
2019 Invention Androgen receptor modulators and methods for their use. Compounds having a structure of formula (...
2017 G/S pharmaceutical preparations for the treatment of cancer
G/S Pharmaceutical preparations for the treatment of cancer.